Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Martin

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Retrovirology|September 13, 2014
Early immune adaptation in HIV-1 revealed by population-level approachesEric Martin, Jonathan M Carlson, Anh Q Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or MutationsGang G Li, Romel Somwar, James Joseph, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2010
Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllersZabrina L Brumme, Chun Li, Toshiyuki Miura, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 17, 2023
Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single-center experienceAnmary A Fernandez, Jacques Simkins, Shweta Anjan, et al.
Clinical and Vaccine Immunology : CVI|December 30, 2011
Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screeningR Brad Jones, Vivek M John, Diana V Hunter, et al.
British Journal of Haematology|March 13, 2016
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402Michael E Williams, Fangxin Hong, Randy D Gascoyne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402Brad S Kahl, Fangxin Hong, Michael E Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2012
Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individualsShao Chong Zhang, Eric Martin, Mariko Shimada, et al.
Plos One|August 4, 2012
A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterationsTao Xie, Giovanni D' Ario, John R Lamb, et al.
Journal of Chemical Information and Modeling|March 28, 2015
FOCUS--Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal ChemistsNikolaus Stiefl, Peter Gedeck, Donovan Chin, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Retrovirology|September 13, 2014
Early immune adaptation in HIV-1 revealed by population-level approachesEric Martin, Jonathan M Carlson, Anh Q Le, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or MutationsGang G Li, Romel Somwar, James Joseph, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 3, 2010
Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllersZabrina L Brumme, Chun Li, Toshiyuki Miura, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 17, 2023
Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single-center experienceAnmary A Fernandez, Jacques Simkins, Shweta Anjan, et al.
Clinical and Vaccine Immunology : CVI|December 30, 2011
Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screeningR Brad Jones, Vivek M John, Diana V Hunter, et al.
British Journal of Haematology|March 13, 2016
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402Michael E Williams, Fangxin Hong, Randy D Gascoyne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 27, 2014
Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402Brad S Kahl, Fangxin Hong, Michael E Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2012
Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individualsShao Chong Zhang, Eric Martin, Mariko Shimada, et al.
Plos One|August 4, 2012
A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterationsTao Xie, Giovanni D' Ario, John R Lamb, et al.
Journal of Chemical Information and Modeling|March 28, 2015
FOCUS--Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal ChemistsNikolaus Stiefl, Peter Gedeck, Donovan Chin, et al.
Pageof 14